Implementation of Code Status Epilepticus in Mexico: Time is Brain
DOI:
https://doi.org/10.31157/an.v29i2.507Keywords:
status epilepticus, Nonconvulsive status epilepticus, EpilepsyAbstract
Introduction: Status epilepticus is a neurological emergency. Its incidence is calculated in 61 cases/ 100,000 persons/year. Mortality has been estimated between 20-80%. This percentage is highly dependent of the efficacy and timing of treatment, determination of etiology and risk factors. Methods: In this narrative synthesis, the authors revised the actual scientific evidence and elaborated a proposal based on expert information for status epilepticus, with a tailored, practical approach specific to Mexico. Results and discussion: We synthesized recent data of medical evidence for status epilepticus, with a practical approach for the improvement of patients with status epilepticus. Conclusions: Patients with status epilepticus must be treated in a standarized manner to prevent morbi-mortality of the disease.
References
Seinfeld S, Goodkin HP, Shinnar S. Status Epilepticus. Cold Spring Harb Perspect Med [Internet]. 2016 Mar 1 [cited 2022 Dec 14];6(3). Available from: /pmc/articles/PMC4772080/ DOI: https://doi.org/10.1101/cshperspect.a022830
Hauser WA. Status epilepticus: epidemiologic considerations. Neurology [Internet]. 1990 May [cited 2019 Dec 1];40(5 Suppl 2):9–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2185441
Martínez-Juárez IE, López-Zapata R, Gómez-Arias B, Bravo-Armenta E, Romero-Ocampo L, Estévez-Cruz Z, et al. Refractory epilepsy: Use of the new definition and related risk factors. A study in the mexican population of a third-level centre. Rev Neurol. 2012;54(3):159–66.
Valdés-Galván RE, González-Calderón G, Castro-Martínez E. Acute seizure epidemiology in a neurological emergency department. Rev Neurol. 2019 Apr 16;68(8):321–5. DOI: https://doi.org/10.33588/rn.6808.2018218
Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of Mortality in Status Epilepticus. Epilepsia. 1994;35(1):27–34. DOI: https://doi.org/10.1111/j.1528-1157.1994.tb02908.x
Scott RC, Surtees RAH, Neville BGR. Status epilepticus: Pathophysiology, epidemiology, and outcomes. Vol. 79, Archives of Disease in Childhood. BMJ Publishing Group; 1998. p. 73–7. DOI: https://doi.org/10.1136/adc.79.1.73
Sánchez Fernández I, Goodkin HP, Scott RC. Pathophysiology of convulsive status epilepticus. Vol. 68, Seizure. W.B. Saunders Ltd; 2019. p. 16–21. DOI: https://doi.org/10.1016/j.seizure.2018.08.002
Nandhagopal R. Generalised convulsive status epilepticus: An overview. Vol. 82, Postgraduate Medical Journal. 2006. p. 723–32. DOI: https://doi.org/10.1136/pgmj.2005.043182
Paredes-Aragón EM, Martínez-Medina S, Gomez-Figueroa E, Martínez-Juárez IE. Estado epiléptico: Innovaciones ante este constante reto neurológico. Innovare: Revista de ciencia y tecnología [Internet]. 2019 Dec 31 [cited 2022 Aug 8];8(2):101–7. Available from: https://www.camjol.info/index.php/INNOVARE/article/view/9081 DOI: https://doi.org/10.5377/innovare.v8i2.9081
Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015 Oct 1;56(10):1515–23. DOI: https://doi.org/10.1111/epi.13121
Trinka E, Leitinger M. Management of Status Epilepticus, Refractory Status Epilepticus, and Super-refractory Status Epilepticus. CONTINUUM Lifelong Learning in Neurology [Internet]. 2022 Apr 1 [cited 2022 Aug 8];28(2):559–602. Available from: https://journals.lww.com/continuum/Fulltext/2022/04000/Management_of_Status_Epilepticus,_Refractory.15.aspx DOI: https://doi.org/10.1212/CON.0000000000001103
Neligan A, Shorvon SD. Frequency and prognosis of convulsive status epilepticus of different causes: A systematic review. Vol. 67, Archives of Neurology. 2010. p. 931–40. DOI: https://doi.org/10.1001/archneurol.2010.169
Rossetti AO, Schindler K, Sutter R, Rüegg S, Zubler F, Novy J, et al. Continuous vs Routine Electroencephalogram in Critically Ill Adults With Altered Consciousness and No Recent Seizure: A Multicenter Randomized Clinical Trial. JAMA Neurol [Internet]. 2020 Oct 1 [cited 2022 Dec 14];77(10):1225–32. Available from: https://jamanetwork.com/journals/jamaneurology/fullarticle/2768699 DOI: https://doi.org/10.1001/jamaneurol.2020.2264
Rodríguez V, Rodden MF, LaRoche SM. Ictal–interictal continuum: A proposed treatment algorithm. Clinical Neurophysiology. 2016 Apr 1;127(4):2056–64. DOI: https://doi.org/10.1016/j.clinph.2016.02.003
Zafar SF, Subramaniam T, Osman G, Herlopian A, Struck AF. Electrographic seizures and ictal–interictal continuum (IIC) patterns in critically ill patients. Epilepsy and Behavior. 2020 May 1;106. DOI: https://doi.org/10.1016/j.yebeh.2020.107037
Husain AM. It HELPS 2NO When to Stop Continuous EEG Monitoring in Critically Ill Patients. Epilepsy Curr [Internet]. 2018 Jul 1 [cited 2022 Oct 9];18(4):233. Available from: /pmc/articles/PMC6145386/ DOI: https://doi.org/10.5698/1535-7597.18.4.233
Bauman K, Devinsky O. Seizure Clusters: Morbidity and Mortality. Front Neurol. 2021 Feb 16;12. DOI: https://doi.org/10.3389/fneur.2021.636045
Jafarpour S, Hirsch LJ, Gaínza-Lein M, Kellinghaus C, Detyniecki K. Seizure cluster: Definition, prevalence, consequences, and management. Seizure. 2019 May 1;68:9–15. DOI: https://doi.org/10.1016/j.seizure.2018.05.013
Silbergleit R, Lowenstein D, Durkalski V, Conwit R. RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): a double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics. Epilepsia [Internet]. 2011 Oct [cited 2022 Dec 14];52 Suppl 8(Suppl 8):45–7. Available from: https://pubmed.ncbi.nlm.nih.gov/21967361/ DOI: https://doi.org/10.1111/j.1528-1167.2011.03235.x
Treatment of Convulsive Status Epilepticus: Recommendations of the Epilepsy Foundation of America’s Working Group on Status Epilepticus. JAMA: The Journal of the American Medical Association. 1993 Aug 18;270(7):854–9. DOI: https://doi.org/10.1001/jama.270.7.854
Claassen J, Mayer SA. Continuous electroencephalographic monitoring in neurocritical care. Curr Neurol Neurosci Rep. 2002;2(6):534–40. DOI: https://doi.org/10.1007/s11910-002-0042-1
Jette N, Hirsch LJ. Continuous electroencephalogram monitoring in critically ill patients. Curr Neurol Neurosci Rep. 2005;5(4):312–21. DOI: https://doi.org/10.1007/s11910-005-0077-1
Scheuer ML. Continuous EEG monitoring in the intensive care unit. Epilepsia [Internet]. 2002 [cited 2022 Dec 14];43 Suppl 3(SUPPL. 3):114–27. Available from: https://pubmed.ncbi.nlm.nih.gov/12060013/ DOI: https://doi.org/10.1046/j.1528-1157.43.s.3.7.x
Der-Nigoghossian C, Rubinos C, Alkhachroum A, Claassen J. Status epilepticus - time is brain and treatment considerations. Curr Opin Crit Care [Internet]. 2019 Dec 1 [cited 2022 Aug 8];25(6):638–46. Available from: https://pubmed.ncbi.nlm.nih.gov/31524720/ DOI: https://doi.org/10.1097/MCC.0000000000000661
Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia [Internet]. 2002 [cited 2022 Dec 14];43(2):146–53. Available from: https://pubmed.ncbi.nlm.nih.gov/11903460/ DOI: https://doi.org/10.1046/j.1528-1157.2002.28501.x
Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Vol. 17, Neurocritical Care. 2012. p. 3–23. DOI: https://doi.org/10.1007/s12028-012-9695-z
Abend NS. Electrographic Status Epilepticus in Critically Ill Children: Epidemiology and Outcome. Epilepsy Behav [Internet]. 2015 Aug 1 [cited 2022 Dec 14];49:223. Available from: /pmc/articles/PMC4536159/ DOI: https://doi.org/10.1016/j.yebeh.2015.03.007
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
September 2022-present © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.
January-September 2022 © The authors. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.
January 2014-December 2021 © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
